By Ellen Capon (Drug Target Review)2023-11-03T14:00:35
How stem cells become enteroendocrine cells using gut organoids could have positive implications for many gastrointestinal diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-05T13:24:00Z
Sponsored by HUB Organoids
2023-01-04T16:08:55
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2023-04-12T15:15:18
Sponsored by Cellistic
2024-01-26T13:22:42
Sponsored by bit.bio
2024-03-08T10:00:25
Sponsored by Molecular Devices
2024-02-06T08:57:06
Sponsored by bit.bio
Site powered by Webvision Cloud